Onderneming Outlook Therapeutics, Inc.
Aandelen
OTLK
US69012T3059
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
8,5 USD | 0,00% | +3,79% | +7,87% |
27/03 | Outlook Therapeutics-aandelen stijgen na BTIG-upgrade | MT |
27/03 | OUTLOOK THERAPEUTICS, INC. : BTIG verhoogt advies naar kopen | ZM |
Vakgebied
Aantal werknemers: 24
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
C. Trenary
CEO | Chief Executive Officer | 66 | 07-07-21 |
Lawrence Kenyon
DFI | Director of Finance/CFO | 58 | 15-09-15 |
Surendra Sharma
CTO | Chief Tech/Sci/R&D Officer | - | 19-01-23 |
Terry Dagnon
COO | Chief Operating Officer | 62 | 01-11-18 |
Alicia Tozier
SAM | Sales & Marketing | - | 02-03-22 |
Joel Prieve
PRN | Corporate Officer/Principal | - | 08-02-22 |
Jeff Evanson
PRN | Corporate Officer/Principal | 55 | 01-11-18 |
Jennifer Kissner
PRN | Corporate Officer/Principal | - | 26-04-19 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Randy Thurman
CHM | Chairman | 74 | 13-04-18 |
Kurt Hilzinger
BRD | Director/Board Member | 63 | 11-12-15 |
C. Trenary
CEO | Chief Executive Officer | 66 | 07-07-21 |
Lawrence Kenyon
DFI | Director of Finance/CFO | 58 | 15-09-15 |
Yazan Haddadin
BRD | Director/Board Member | 48 | 31-10-17 |
Julian Gangolli
BRD | Director/Board Member | 66 | 20-04-20 |
Gerd Auffarth
BRD | Director/Board Member | 59 | 20-04-20 |
Julia Haller
BRD | Director/Board Member | 69 | 11-08-22 |
Director/Board Member | 39 | 11-09-17 | |
Andong Huang
BRD | Director/Board Member | 27 | 19-06-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 22 298 542 | 13 636 212 ( 61,15 %) | 0 | 61,15 % |
Bedrijfsgegevens
Outlook Therapeutics, Inc.
485 Route 1 South Building F, Suite 320
08852, Iselin
+609 619 3990
http://www.outlooktherapeutics.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+7,87% | 198 mln. | |
+26,28% | 42,68 mld. | |
-3,99% | 42,4 mld. | |
+45,32% | 40,04 mld. | |
-6,20% | 28,31 mld. | |
+6,36% | 24,94 mld. | |
-21,47% | 18,96 mld. | |
+27,58% | 12,3 mld. | |
-2,75% | 11,95 mld. | |
-2,02% | 11,55 mld. |
- Beurs
- Aandelen
- Koers OTLK
- Onderneming Outlook Therapeutics, Inc.